← Leaderboards
Rafick-Pierre Sekaly
University Of Montreal
$71,470,176
Attributed
$81,491,367
Total exposure
29
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$114,731,763 · 31
By mechanism
U19$49,456,054 · 10
R01$16,350,136 · 4
UM1$15,031,786 · 1
P01$10,550,194 · 9
U01$9,618,150 · 1
R37$7,167,203 · 1
Top collaborators
- Steven Grant Deeks5 shared
- Joseph M Mccune5 shared
- Paula M Cannon3 shared
- Sumit K Chanda3 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmune ResponseImmuneT-LymphocyteMolecularPathway InteractionsLeadHiv InfectionsVirusViralInfectionCd4 Positive T LymphocytesCytokineT Memory CellMediatingTissuesImmune SystemAntibodiesResponseGenesNatural ImmunitySamplingMemoryMonitor
Grant awards (125)
Reversing Immune Dysfunction for HIV-1 Eradication$5,028,890
UM1 · FY2025 · AI
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir$1,227,889
P01 · FY2025 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$666,681
R37 · FY2025 · AI · contact PI
Innate and adaptive immune factors in the acquisition, expulsion and transmission of influenza virus infection$414,939
P01 · FY2025 · AI · contact PI
Reversing Immune Dysfunction for HIV-1 Eradication$5,001,089
UM1 · FY2024 · AI
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir$1,219,661
P01 · FY2024 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$738,490
R37 · FY2024 · AI · contact PI
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy$417,652
P01 · FY2024 · AI · contact PI
I2 Control= Modulating Innate Immunity to Achieve Control of HIV$403,938
P01 · FY2024 · AI · contact PI
MOIR - Administrative Core$91,445
P01 · FY2024 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$88,878
U54 · FY2024 · CA · contact PI
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir$1,293,876
P01 · FY2023 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$793,338
R37 · FY2023 · AI · contact PI
I2 Control= Modulating Innate Immunity to Achieve Control of HIV$453,739
P01 · FY2023 · AI · contact PI
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy$420,817
P01 · FY2023 · AI · contact PI
MOIR - Administrative Core$96,248
P01 · FY2023 · AI · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$87,192
P30 · FY2023 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$769,644
R37 · FY2022 · AI · contact PI
Core C - Modeling Core$405,639
U19 · FY2022 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$359,168
U54 · FY2022 · CA · contact PI
Emory/Georgia TB Research Advancement Center (TRAC)$197,281
P30 · FY2022 · AI · contact PI
Reversing Immune Dysfunction for HIV-1 Eradication$5,001,807
UM1 · FY2021 · AI
Resetting immune homeostasis: a non-invasive approach towards HIV eradication$1,648,370
U01 · FY2021 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$1,540,312
R37 · FY2021 · AI · contact PI
Core C - Modeling Core$410,867
U19 · FY2021 · AI · contact PI
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.$228,809
U19 · FY2021 · AI · contact PI
Bioinformatics Core: Core C$193,233
U19 · FY2021 · AI · contact PI
Resetting immune homeostasis: a non-invasive approach towards HIV eradication$1,347,054
U01 · FY2020 · AI · contact PI
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials$1,046,952
R01 · FY2020 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$795,459
U54 · FY2020 · CA · contact PI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir$743,904
R01 · FY2020 · DA · contact PI
?Resetting immune homeostasis: a non-invasive approach towards HIV eradication$667,065
U01 · FY2020 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$636,715
R37 · FY2020 · AI · contact PI
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection$531,979
R01 · FY2020 · DA · contact PI
Core C - Modeling Core$411,357
U19 · FY2020 · AI · contact PI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.$315,340
R01 · FY2020 · DA · contact PI
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.$311,500
U19 · FY2020 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$308,501
R37 · FY2020 · AI · contact PI
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.$249,457
U19 · FY2020 · AI · contact PI
Bioinformatics Core: Core C$228,855
U19 · FY2020 · AI · contact PI
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection$212,725
R01 · FY2020 · DA · contact PI
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials$150,971
R01 · FY2020 · AI · contact PI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.$1,176,111
R01 · FY2019 · DA · contact PI
?Resetting immune homeostasis: a non-invasive approach towards HIV eradication$1,096,736
U01 · FY2019 · AI · contact PI
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials$870,724
R01 · FY2019 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$838,315
R37 · FY2019 · AI · contact PI
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection$670,632
R01 · FY2019 · DA · contact PI
Core C - Modeling Core$410,868
U19 · FY2019 · AI · contact PI
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.$309,187
U19 · FY2019 · AI · contact PI
Integrated Functional Genomics$236,571
U19 · FY2019 · HL · contact PI
Bioinformatics Core: Core C$54,412
U19 · FY2019 · AI · contact PI
?Resetting immune homeostasis: a non-invasive approach towards HIV eradication$2,553,341
U01 · FY2018 · AI · contact PI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.$1,179,414
R01 · FY2018 · DA · contact PI
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials$923,551
R01 · FY2018 · AI · contact PI
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV$875,207
R37 · FY2018 · AI · contact PI
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.$789,910
U19 · FY2018 · AI · contact PI
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection$678,582
R01 · FY2018 · DA · contact PI
Integrated Functional Genomics$236,571
U19 · FY2018 · HL · contact PI
Bioinformatics Core: Core C$40,138
U19 · FY2018 · AI · contact PI
?Resetting immune homeostasis: a non-invasive approach towards HIV eradication$2,305,584
U01 · FY2017 · AI · contact PI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.$1,182,718
R01 · FY2017 · DA · contact PI
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials$1,019,293
R01 · FY2017 · AI · contact PI
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection$683,045
R01 · FY2017 · DA · contact PI
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.$287,394
U19 · FY2017 · AI · contact PI
Targeting the IL-10 pathway for an HIV Cure$284,963
R21 · FY2017 · AI · contact PI
Integrated Functional Genomics$236,571
U19 · FY2017 · HL · contact PI
Bioinformatics Core: Core C$50,720
U19 · FY2017 · AI · contact PI
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials$1,264,663
R01 · FY2016 · AI · contact PI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.$1,229,898
R01 · FY2016 · DA · contact PI
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection$717,500
R01 · FY2016 · DA · contact PI
Integrated Functional Genomics$236,571
U19 · FY2016 · HL · contact PI
Targeting the IL-10 pathway for an HIV Cure$201,087
R21 · FY2016 · AI · contact PI
DARE: Delaney AIDS Research Enterprise to find a cure.$5,807,143
U19 · FY2015 · AI
Targeting the PD - 1 pathway to eradicate SIV/HIV$1,790,318
U19 · FY2015 · AI · contact PI
Systems Biology$681,422
U19 · FY2015 · AI · contact PI
Integrated Functional Genomics$252,779
U19 · FY2015 · HL · contact PI
Targeting mechanisms of T cell homeostasis to purge the HIV reservoir$210,838
U19 · FY2015 · AI · contact PI
DARE: Delaney AIDS Research Enterprise to find a cure.$7,309,244
U19 · FY2014 · AI
Targeting mechanisms of T cell homeostasis to purge the HIV reservoir$1,723,647
U19 · FY2014 · AI · contact PI
Systems Biology$706,278
U19 · FY2014 · AI · contact PI
Targeting the PD - 1 pathway to eradicate SIV/HIV$543,749
U19 · FY2014 · AI · contact PI
Immune Array and Bioinformatics$315,707
P01 · FY2014 · AI · contact PI
DARE: Delaney AIDS Research Enterprise to find a cure.$5,568,822
U19 · FY2013 · AI
Targeting mechanisms of T cell homeostasis to purge the HIV reservoir$1,136,267
U19 · FY2013 · AI · contact PI
Novel Concepts for the Eradication of HIV$871,184
DP1 · FY2013 · DA · contact PI
Targeting the PD - 1 pathway to eradicate SIV/HIV$769,283
U19 · FY2013 · AI · contact PI
Systems Biology$675,824
U19 · FY2013 · AI · contact PI
Immune Array and Bioinformatics$539,082
P01 · FY2013 · AI · contact PI
Enhancing Vaccine Induced T and B Cell Memory Through DC Targeting$382,926
U19 · FY2013 · AI · contact PI
DARE: Delaney AIDS Research Enterprise to find a cure.$6,511,956
U19 · FY2012 · AI
Systems Biology$1,164,123
U19 · FY2012 · AI · contact PI
Novel Concepts for the Eradication of HIV$907,484
DP1 · FY2012 · DA · contact PI
Targeting the PD - 1 pathway to eradicate SIV/HIV$630,490
U19 · FY2012 · AI · contact PI
Targeting mechanisms of T cell homeostasis to purge the HIV reservoir$580,362
U19 · FY2012 · AI · contact PI
Immune Array and Bioinformatics$524,235
P01 · FY2012 · AI · contact PI
Immune Activation Promotes PD1 Ex and Immune Dysfunction in Chronic HIV Infection$360,952
P01 · FY2012 · AI · contact PI
Enhancing Vaccine Induced T and B Cell Memory Through DC Targeting$287,205
U19 · FY2012 · AI · contact PI
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunction$267,411
P01 · FY2012 · AI · contact PI
Novel Concepts for the Eradication of HIV$169,010
DP1 · FY2012 · DA · contact PI
DARE: Delaney AIDS Research Enterprise to find a cure.$4,301,805
U19 · FY2011 · AI
Novel Concepts for the Eradication of HIV$907,484
DP1 · FY2011 · DA · contact PI
Targeting mechanisms of T cell homeostasis to purge the HIV reservoir$834,941
U19 · FY2011 · AI · contact PI
Systems Biology$712,541
U19 · FY2011 · AI · contact PI
Targeting the PD - 1 pathway to eradicate SIV/HIV$530,035
U19 · FY2011 · AI · contact PI
Immune Activation Promotes PD1 Ex and Immune Dysfunction in Chronic HIV Infection$363,375
P01 · FY2011 · AI · contact PI
Enhancing Vaccine Induced T and B Cell Memory Through DC Targeting$341,525
U19 · FY2011 · AI · contact PI
Immune Array and Bioinformatics$325,359
P01 · FY2011 · AI · contact PI
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunction$265,962
P01 · FY2011 · AI · contact PI
Novel Concepts for the Eradication of HIV$919,050
DP1 · FY2010 · DA · contact PI
Immune Activation Promotes PD1 Ex and Immune Dysfunction in Chronic HIV Infection$372,361
P01 · FY2010 · AI · contact PI
Enhancing Vaccine Induced T and B Cell Memory Through DC Targeting$344,975
U19 · FY2010 · AI · contact PI
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunction$144,355
P01 · FY2010 · AI · contact PI
Novel Concepts for the Eradication of HIV$770,000
DP1 · FY2009 · DA · contact PI
Immune Activation Promotes PD1 Ex and Immune Dysfunction in Chronic HIV Infection$365,252
P01 · FY2009 · AI · contact PI
Enhancing Vaccine Induced T and B Cell Memory Through DC Targeting$328,926
U19 · FY2009 · AI · contact PI
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunction$146,083
P01 · FY2009 · AI · contact PI
Immune Activation Promotes PD1 Ex and Immune Dysfunction in Chronic HIV Infection$371,191
P01 · FY2008 · AI · contact PI
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunction$148,665
P01 · FY2008 · AI · contact PI
Effect of Viral Escape on Memory T Cell Maturation$388,341
R01 · FY2006 · AI · contact PI
Effect of Viral Escape on Memory T Cell Maturation$385,894
R01 · FY2005 · AI
Effect of Viral Escape on Memory T Cell Maturation$388,732
R01 · FY2004 · AI
T CELL IMMUNOLOGY$0
P01 · FY2002 · AI
FACTORS CONTROLLING T CELL RESPONSE IN PRIMARY HIV$291,055
R01 · FY2001 · AI
T CELL IMMUNOLOGY$0
P01 · FY2001 · AI
FACTORS CONTROLLING T CELL RESPONSE IN PRIMARY HIV$298,112
R01 · FY2000 · AI